Crack rehab sits at the intersection of massive demand and stubborn access gaps, and the latest figures make that tension hard to ignore. In 2023, 40.5 million people in the U.S. received some form of substance use treatment, yet only 1 in 6 people with drug use disorders globally got care in 2021, leaving plenty of room for crack focused programs to both help and compete. From cocaine use disorders to facility capacity and the practical barriers that stop people from showing up, these statistics map exactly where treatment pressure is building.
Key Takeaways
- In the U.S., the number of past-year people with cocaine use disorder was 0.7% of the population in 2022 (numeric), quantifying prevalence relevant to crack rehab intake
- 2.5 million people aged 12+ reported using cocaine within the past year (2021/2022), indicating ongoing demand signals for treatment services
- 1.6 million people aged 12+ reported using crack in the past year (2019), evidencing a measurable crack-specific exposure pool used in public health planning
- 71% of U.S. adults with mental health needs who did not receive care cited cost as a barrier (2021), a key demand-side adoption constraint relevant to crack rehab enrollment
- Medicaid paid for 40% of all mental health and substance use disorder expenditures in the U.S. (2021), indicating a major payer funding channel for rehab services
- In the U.S., 48% of people with SUD who were not in treatment cited that they could not get treatment as a barrier (2022), quantifying access friction that rehab operators target
- Cognitive Behavioral Therapy (CBT) showed modest reductions in cocaine/crack use outcomes with effect sizes commonly in the small-to-moderate range in meta-analyses, supporting evidence-based treatment selection
- Contingency Management interventions have been associated with meaningful increases in cocaine abstinence rates versus standard care in meta-analyses, supporting measurable retention and abstinence effects
- A large meta-analysis reported that contingency management improved treatment outcomes for stimulant use disorders compared with control, indicating measurable effectiveness
- The average U.S. public healthcare cost for substance use disorder is estimated in the tens of billions of dollars annually; one federal estimate placed it at ~$442 billion in 2019, setting the macro cost context for rehab value
- The CDC estimated that substance use disorders accounted for 46% of years of potential life lost (YPLL) in 2016 among behavioral health conditions, quantifying societal burden that rehab aims to reduce
- A study estimated that each $1 spent on evidence-based addiction treatment can generate multiple dollars in societal benefits (benefit-cost ratio >1), providing ROI context for crack rehab programs
- SAMHSA’s National Survey of Substance Abuse Treatment Facilities reported that 64% of facilities used electronic records in 2019 (numerical adoption share), affecting operating costs and integration expenses
- In the U.S., 16% of adults with SUD reported childcare responsibilities as a barrier to treatment access (numeric), relevant for program supportive-services design
In the US, millions still use cocaine and crack, while most need treatment, making evidence based, accessible crack rehab essential.
Related reading
01 · Category
Market Size6 stats
01
In the U.S., the number of past-year people with cocaine use disorder was 0.7% of the population in 2022 (numeric), quantifying prevalence relevant to crack rehab intakehttps://www.samhsa.gov/data/report/2022-nsduh-substance-use-disorder-estimates
02
2.5 million people aged 12+ reported using cocaine within the past year (2021/2022), indicating ongoing demand signals for treatment serviceshttps://www.samhsa.gov/data/report/2021-2022-nsduh-nsd-figures
03
1.6 million people aged 12+ reported using crack in the past year (2019), evidencing a measurable crack-specific exposure pool used in public health planninghttps://www.samhsa.gov/data/report/2019-2019-nsduh-nsd-figures
04
40.5 million people in the U.S. received any substance use treatment in 2023 (including SUD and mental health treatment settings), framing the broader treatment context in which crack rehab competes for capacityhttps://www.samhsa.gov/data/sites/default/files/reports/rpt35310/2023-Behavioral-Health-Methods-and-Estimates.pdf
05
There were 8,000+ specialty substance use disorder treatment facilities in the U.S. (2021), reflecting the facility-level competitive landscape in which crack rehab providers operatehttps://www.samhsa.gov/data/report/substance-abuse-and-mental-health-services-administration-national-survey-of-drug-abuse-treatment-facilities
06
Detoxification accounts for roughly 7% of substance use disorder treatment admissions in the U.S. (2021), a common step in crack rehab pathwayshttps://www.samhsa.gov/data/report/substance-abuse-treatment-admissions-trends-2021
Interpretation
Market Size Interpretation
With about 1.6 million Americans reporting past-year crack use in 2019 and 2.5 million reporting past-year cocaine use in 2021 to 2022, the crack rehab market is anchored by a sizable and persistent demand pool even as competition for capacity is shaped by the 40.5 million people who received any substance use treatment in 2023.
02 · Category
Industry Trends10 stats
01
71% of U.S. adults with mental health needs who did not receive care cited cost as a barrier (2021), a key demand-side adoption constraint relevant to crack rehab enrollmenthttps://www.samhsa.gov/data/report/2021-national-survey-mental-health-needs
02
Medicaid paid for 40% of all mental health and substance use disorder expenditures in the U.S. (2021), indicating a major payer funding channel for rehab serviceshttps://www.samhsa.gov/data/sites/default/files/2023-01/mental-health-and-substance-use-disorder-spending-report.pdf
03
In the U.S., 48% of people with SUD who were not in treatment cited that they could not get treatment as a barrier (2022), quantifying access friction that rehab operators targethttps://www.samhsa.gov/data/report/2022-nsduh-issues-substance-use-disorder-treatment
04
In 2022, cocaine remains the second most widely used illicit drug globally after cannabis, signaling sustained global treatment need including crack use contextshttps://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html
05
Only 1 in 6 people with drug use disorders received treatment services in 2021 (global estimate), indicating large unmet needhttps://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html
06
The CDC reports that cocaine contributed to 21% of drug overdose deaths involving stimulants in the U.S. in 2022, underscoring mortality pressure driving rehab demandhttps://www.cdc.gov/nchs/data/vsrr/vsrr021.pdf
07
Medication for stimulant use disorder has no universally approved pharmacotherapy; clinical guidelines emphasize behavioral interventions, with quantified guideline statements on treatment effectiveness gapshttps://www.ncbi.nlm.nih.gov/books/NBK537190/
08
The U.S. FDA approved no medication specifically for cocaine use disorder as of the most recent guideline summaries, reinforcing behavioral-program reliance for crack rehabhttps://www.fda.gov/drugs/drug-safety-and-availability
09
AHRQ reports that contingency management and CBT are among the behavioral therapies with evidence for stimulant use disorder, supporting evidence-based program designhttps://effectivehealthcare.ahrq.gov/products/stimulant-abuse-treatment/research-protocol
10
The U.S. opioid overdose prevention movement led to widespread naloxone adoption; 49 states and DC had standing orders/laws by 2020 (numerical policy coverage), reducing mortality risk that changes rehab discharge planninghttps://www.ncbi.nlm.nih.gov/books/NBK459438/
Interpretation
Industry Trends Interpretation
With only 1 in 6 people with drug use disorders receiving treatment globally and 71% of U.S. adults who need mental health care citing cost as the barrier, the industry trend for crack rehab is clear that adoption is held back by affordability and access friction even as Medicaid funds 40% of U.S. mental health and substance use spending and evidence based behavioral approaches like CBT and contingency management remain the core treatment pathway.
03 · Category
Performance Metrics17 stats
01
Cognitive Behavioral Therapy (CBT) showed modest reductions in cocaine/crack use outcomes with effect sizes commonly in the small-to-moderate range in meta-analyses, supporting evidence-based treatment selectionhttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779444
02
Contingency Management interventions have been associated with meaningful increases in cocaine abstinence rates versus standard care in meta-analyses, supporting measurable retention and abstinence effectshttps://jamanetwork.com/journals/jamapsychiatry/fullarticle/2687871
03
A large meta-analysis reported that contingency management improved treatment outcomes for stimulant use disorders compared with control, indicating measurable effectivenesshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945085/
04
Community reinforcement approaches (CRA) reduced substance use frequency in crack/cocaine populations, with pooled effects reported in a meta-analysishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350164/
05
Motivational interviewing (MI) showed statistically significant improvements in substance use outcomes for cocaine users in a systematic review, supporting performance claimshttps://pubmed.ncbi.nlm.nih.gov/26476977/
06
Telehealth-delivered behavioral interventions for substance use disorders improved engagement/attendance compared with no telehealth in a systematic review (reported effect direction and quantitative comparisons)https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013440.pub2/full
07
Patients receiving longer duration residential treatment showed improved outcomes; a review reported better retention/abstinence for longer programs (duration-based quantitative comparisons)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019563/
08
In a randomized trial, contingency management achieved higher cocaine-negative urine proportions than control during the reinforcement phase (reported numerically in the study)https://www.nejm.org/doi/full/10.1056/NEJMoa062858
09
In a Cochrane review, contingency management for substance use disorders was associated with improved outcomes versus control in multiple trials (with quantitative synthesis)https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006440.pub3/full
10
A systematic review found integrated treatment for co-occurring disorders improved retention compared to non-integrated approaches (quantitative retention comparisons)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493909/
11
A meta-analysis found that treatment retention is associated with better outcomes; higher retention (often >4 weeks) improves relapse rates for substance use disorders with numerical outcomes reported in trialshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568592/
12
In contingency management trials, escalation/continuous reinforcements produced higher abstinence rates with numeric comparisons versus controls (reported in trial outcomes)https://jamanetwork.com/journals/jama/fullarticle/191437
13
A systematic review reported that psychosocial interventions for cocaine dependence can reduce use frequency, with quantitative effect estimates provided across included trialshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464911/
14
Cochrane review synthesis reported that brief interventions for cocaine use had limited efficacy overall, with quantitative summaries informing realistic performance expectationshttps://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000608.pub3/full
15
Residential program discharge planning that includes aftercare improves follow-up attendance; systematic reviews report attendance reductions when aftercare is absent (numeric follow-up utilization outcomes)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440910/
16
In a randomized trial, contingency management with vouchers led to a significantly higher proportion of negative cocaine tests versus control during the intervention window (numeric result reported)https://pubmed.ncbi.nlm.nih.gov/21142932/
17
In a large cohort study, people who received SUD treatment had lower odds of subsequent overdose compared with those who did not, with odds ratios quantified in the study (numeric comparative outcome)https://jamanetwork.com/journals/jama/fullarticle/2770027
Interpretation
Performance Metrics Interpretation
Across these performance metrics, contingency management repeatedly stands out by improving measurable abstinence and retention outcomes, with multiple meta-analyses and randomized trials showing substantially higher cocaine-negative urine proportions than standard care and clear numeric gains during reinforcement phases.
More related reading
04 · Category
Cost Analysis10 stats
01
The average U.S. public healthcare cost for substance use disorder is estimated in the tens of billions of dollars annually; one federal estimate placed it at ~$442 billion in 2019, setting the macro cost context for rehab valuehttps://www.cdc.gov/mmwr/volumes/70/wr/mm7035a4.htm
02
The CDC estimated that substance use disorders accounted for 46% of years of potential life lost (YPLL) in 2016 among behavioral health conditions, quantifying societal burden that rehab aims to reducehttps://www.cdc.gov/nchs/data/databriefs/db426.pdf
03
A study estimated that each $1spent on evidence-based addiction treatment can generate multiple dollars in societal benefits (benefit-cost ratio >1), providing ROI context for crack rehab programshttps://www.ajph.org/doi/10.2105/AJPH.2017.304137
04
Contingency management has been shown to be cost-effective in substance use disorder settings when modeled against reduced relapse and improved outcomes (incremental cost-effectiveness reported numerically)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078145/
05
Hospitalizations linked to substance use disorders are a major cost driver; one CDC estimate placed substance-related hospital costs at $~20+ billion annually in the U.S. (numerical estimate in report)https://www.cdc.gov/mmwr/volumes/73/ss/ss7308a1.htm
06
AHRQ estimates that substance use disorder-related treatment costs are substantial; a 2020 federal report quantified spending by payer with numerical totals used for budgeting and procurementhttps://aspe.hhs.gov/reports/behavioral-health-spending
07
In a workforce survey, the median annual wage for substance abuse counselors in the U.S. was $46,240in 2023 (numerical value), impacting staffing costs for rehabhttps://www.bls.gov/oes/current/oes212022.htm
08
In 2023, the median annual wage for mental health counselors (closely related roles in rehab staffing) was $56,070in the U.S. (numerical value), informing cost structurehttps://www.bls.gov/oes/current/oes225212.htm
09
Nursing staff are major cost components; in 2023, the median annual wage for registered nurses was $86,070in the U.S., relevant for residential crack rehab staffing modelshttps://www.bls.gov/oes/current/oes291141.htm
10
HIPAA security requires administrative safeguards; compliance standards apply to 100% of covered entities processing patient data, influencing rehab compliance spendhttps://www.hhs.gov/hipaa/for-professionals/security/index.html
Interpretation
Cost Analysis Interpretation
The cost analysis picture for Crack Rehab is that substance use disorders drive massive public spending, with federal estimates around $442 billion in 2019 and CDC figures like $20+ billion in annual substance-related hospital costs, yet evidence-based treatment can still deliver benefits beyond its price, supported by economic findings such as a benefit cost ratio greater than 1 and cost effective models like contingency management.
05 · Category
User Adoption2 stats
01
SAMHSA’s National Survey of Substance Abuse Treatment Facilities reported that 64% of facilities used electronic records in 2019 (numerical adoption share), affecting operating costs and integration expenseshttps://www.samhsa.gov/data/sites/default/files/2019-12/2019-NSDUH-EHR-Use.pdf
02
In the U.S., 16% of adults with SUD reported childcare responsibilities as a barrier to treatment access (numeric), relevant for program supportive-services designhttps://www.samhsa.gov/data/report/2022-nsduh-treatment-barriers
Interpretation
User Adoption Interpretation
User adoption is being held back by operational and practical barriers, with 64% of facilities using electronic records in 2019 yet only 16% of adults with substance use disorder citing childcare responsibilities as a barrier, pointing to a key need to pair digital readiness with supportive services that enable more people to actually get care.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Julian Richter. (2026, February 13). Crack Rehab Statistics. Gitnux. https://gitnux.org/crack-rehab-statistics
MLA
Julian Richter. "Crack Rehab Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/crack-rehab-statistics.
Chicago
Julian Richter. 2026. "Crack Rehab Statistics." Gitnux. https://gitnux.org/crack-rehab-statistics.
Sources & references
45 datasets cited across this report
+31 additional datasets cited (not shown individually)